319 related articles for article (PubMed ID: 19601724)
1. Drug interactions.
Boobis A; Watelet JB; Whomsley R; Benedetti MS; Demoly P; Tipton K
Drug Metab Rev; 2009; 41(3):486-527. PubMed ID: 19601724
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.
Venkatakrishnan K; Obach RS; Rostami-Hodjegan A
Xenobiotica; 2007; 37(10-11):1225-56. PubMed ID: 17968744
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and induction of human cytochrome P450 enzymes: current status.
Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
[TBL] [Abstract][Full Text] [Related]
4. [Anti-allergy drugs].
Shimizu Y; Dobashi K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():419-22. PubMed ID: 15658353
[No Abstract] [Full Text] [Related]
5. Gender and interindividual variability in pharmacokinetics.
Nicolas JM; Espie P; Molimard M
Drug Metab Rev; 2009; 41(3):408-21. PubMed ID: 19601720
[TBL] [Abstract][Full Text] [Related]
6. Drug interactions: concerns and current approaches.
Nassar AE; Talaat RE; Tokuno H
IDrugs; 2007 Jan; 10(1):47-52. PubMed ID: 17187315
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
Grime KH; Bird J; Ferguson D; Riley RJ
Eur J Pharm Sci; 2009 Feb; 36(2-3):175-91. PubMed ID: 19013237
[TBL] [Abstract][Full Text] [Related]
8. In human therapy, is the drug-drug interaction or the adverse drug reaction the issue?
du Souich P
Can J Clin Pharmacol; 2001; 8(3):153-61. PubMed ID: 11574898
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic protein-drug interactions and implications for drug development.
Huang SM; Zhao H; Lee JI; Reynolds K; Zhang L; Temple R; Lesko LJ
Clin Pharmacol Ther; 2010 Apr; 87(4):497-503. PubMed ID: 20200513
[TBL] [Abstract][Full Text] [Related]
10. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
[TBL] [Abstract][Full Text] [Related]
11. Drug metabolism and pharmacokinetics.
Benedetti MS; Whomsley R; Poggesi I; Cawello W; Mathy FX; Delporte ML; Papeleu P; Watelet JB
Drug Metab Rev; 2009; 41(3):344-90. PubMed ID: 19601718
[TBL] [Abstract][Full Text] [Related]
12. From pharmacokinetics to therapeutics.
Church MK; Gillard M; Sargentini-Maier ML; Poggesi I; Campbell A; Benedetti MS
Drug Metab Rev; 2009; 41(3):455-74. PubMed ID: 19601722
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic management of allergic diseases.
Watelet JB; Gillard M; Benedetti MS; Lelièvre B; Diquet B
Drug Metab Rev; 2009; 41(3):301-43. PubMed ID: 19601717
[TBL] [Abstract][Full Text] [Related]
14. Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes.
Nekvindová J; Anzenbacher P
Ceska Slov Farm; 2007 Jul; 56(4):165-73. PubMed ID: 17969314
[TBL] [Abstract][Full Text] [Related]
15. Predicting in vivo drug interactions from in vitro drug discovery data.
Wienkers LC; Heath TG
Nat Rev Drug Discov; 2005 Oct; 4(10):825-33. PubMed ID: 16224454
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
Zhang L; Reynolds KS; Zhao P; Huang SM
Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
Saggar S; Maibach HI
Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
[TBL] [Abstract][Full Text] [Related]
18. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
Muruganandan S; Sinal CJ
Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
[TBL] [Abstract][Full Text] [Related]
19. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
Foti RS; Wahlstrom JL
IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
[TBL] [Abstract][Full Text] [Related]
20. Herb-drug interactions: an overview of the clinical evidence.
Izzo AA
Fundam Clin Pharmacol; 2005 Feb; 19(1):1-16. PubMed ID: 15660956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
